semaglutide class action lawsuit Ozempic Lawsuit: Protect Your Rights Now Lawsuits claiming Ozempic, other GLP-1s

In trials to assess semaglutides effectiveness for reducing the risk of major cardiovascular events in adults, increases in total bilirubin greater than or equal to 3 times the upper limit of normal were seen in .3% of people taking Wegovy versus .2% of people taking the placebo

After a higher dose: Nausea or stomach upset often lasts 37 days Appetite changes may last 12 weeks Symptoms typically fade as the body adapts to the new dose Gradual dose increases tend to make this transition easier

It does this by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1)

Selection of Included Studies Appendix 2

Impact On Weight Management Both medications support weight loss, but tirzepatide demonstrates greater effectiveness

Practice mindful eating and stop when you feel satisfied